Looking back on my lifestyle before the Whole30, my personal recipe for making unhealthy food choices typically consisted of being hungry and on a time crunch, which meant I'd choose whatever was most convenient (read: something overly processed from the vending machine). "Whole30 requires you to plan ahead, mainly so you stay 'compliant' and don’t go hungry," explains Liz McMahon, RDN. "Planning out meals and batch cooking ensures you have healthier food available and won’t constantly be reaching for fast food options." Making pre-planning a habit — even when I'm dining out — helps keep me on track even when I'm not following the Whole30.
The Open, introduced in 2011 and so-called because participation is open to anyone, is held over five weeks in February–March; a new workout is released on each Thursday night (Pacific Time) and competitors complete the workout and submit their scores online by Monday evening, with either a video or validation by a CrossFit affiliate. Since 2013, Open workout announcements have been broadcast live, and featured two or more past CrossFit Games athletes competing head-to-head immediately following the workout description. Beginning with the 2019 Games, the top athlete from each country and the top 20 overall Open finishers qualify directly to the Games. The Open is also used for seeding purposes at the Games even if an athlete qualified through the sanctioned events; if an athlete qualifies through a sanctioned event but does not do the Open, they will be seeded at the bottom.
The WHO trial (so named because the international team of principal investigators contained World Health Organization members) tested the potential of clofibrate, a “pre-statin” cholesterol-lowering agent, to reduce heart attack morbidity and mortality. The investigators ultimately concluded that clofibrate "cannot be recommended as a lipid-lowering drug for community-wide primary prevention of ischaemic heart disease.” Nevertheless, clofibrate remained in use until 2002, when it was pulled for increasing cancer rates. In their review of studies such as the WHO trial, Uffe Ravnskov and David Diamond observe, “Despite the largely disappointing findings from 50 years of cholesterol lower[ing] trials, the indictment and conviction of cholesterol as the causal agent in CVD [cardiovascular disease] has stood the test of time. … [Yet] the grand effort to reduce cholesterol as a strategy to improve health has failed.”